Calcipotriene (MC903)

Synonyms: Calcipotriol

Calcipotriene (MC903) is a synthetic derivative of calcitriol, a form of vitamin D. It can induce differentiation and suppresses proliferation of keratinocytes, reversing abnormal keratinocyte changes in psoriasis, and lead to normalization of epidermal growth. Calcipotriol is a synthetic VitD3 analogue with a high affinity for the vitamin D receptor.

Calcipotriene (MC903) Chemical Structure

Calcipotriene (MC903) Chemical Structure

CAS No. 112965-21-6

Purity & Quality Control

Calcipotriene (MC903) Related Products

Biological Activity

Description Calcipotriene (MC903) is a synthetic derivative of calcitriol, a form of vitamin D. It can induce differentiation and suppresses proliferation of keratinocytes, reversing abnormal keratinocyte changes in psoriasis, and lead to normalization of epidermal growth. Calcipotriol is a synthetic VitD3 analogue with a high affinity for the vitamin D receptor.
In vitro
In vitro Calcipotriene enhances IL-10 secretion in psoriatic skin and in human T cells, induces secretion of type 2 cytokines by T cells and, significantly modulates the differentiation of DCs and T cells[1].
Cell Research Cell lines Monocytes (CD14+ cells)-derived DCs
Concentrations 100 nM
Incubation Time 24 h or 3 days
Method Cells are treated in duplicates with 100 nM calcipotriol, 1 mM betamethasone (BDP), combination of calcipotriol and betamethasone (100 nM/1 mM; ratio 1:10 as in the fixed-combination product) or a corresponding vehicle control (0.1% DMSO). Treatment is applied after the first 5 days in culture and before and throughout the 3 days of activation with LPS and IFN-γ or two days after activation with LPS and IFN-γ and throughout the last 24 h of activation.
In Vivo
In vivo Calcipotriol suppresses skin cancer development in mice in a TSLP-dependent manner. Calcipotriol is a well-tolerated topical medication for psoriasis. The low concentration of calcipotriol in the clinically available formulation (0.005% ointment) dampens its effect against skin cancer development in mice[2].
Animal Research Animal Models genetically engineered mouse models
Dosages 80 nM
Administration topical
NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06203470 Not yet recruiting
Psoriasis Vulgaris
Assiut University
June 2024 Phase 4
NCT05954104 Completed
Alopecia Areata
Egymedicalpedia
July 1 2023 Not Applicable
NCT03596073 Terminated
Breast Cancer
Massachusetts General Hospital
November 7 2018 Phase 1
NCT03476746 Completed
Healthy
LEO Pharma
March 20 2018 Phase 1

Chemical Information & Solubility

Molecular Weight 412.60 Formula

C27H40O3

CAS No. 112965-21-6 SDF Download Calcipotriene (MC903) SDF
Smiles CC(C=CC(C1CC1)O)C2CCC3C2(CCCC3=CC=C4CC(CC(C4=C)O)O)C
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 83 mg/mL ( (201.16 mM) Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Ethanol : 83 mg/mL

Water : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Calcipotriene (MC903) | Calcipotriene (MC903) ic50 | Calcipotriene (MC903) price | Calcipotriene (MC903) cost | Calcipotriene (MC903) solubility dmso | Calcipotriene (MC903) purchase | Calcipotriene (MC903) manufacturer | Calcipotriene (MC903) research buy | Calcipotriene (MC903) order | Calcipotriene (MC903) mouse | Calcipotriene (MC903) chemical structure | Calcipotriene (MC903) mw | Calcipotriene (MC903) molecular weight | Calcipotriene (MC903) datasheet | Calcipotriene (MC903) supplier | Calcipotriene (MC903) in vitro | Calcipotriene (MC903) cell line | Calcipotriene (MC903) concentration | Calcipotriene (MC903) nmr